The double threat: bacterial and fungal co-/superinfection in viral pneumonia
Arsah Asis1, Alejandro Rodríguez2, Luis Felipe Reyes3,4,5
1Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St James's Hospital, Dublin, Ireland.
Introduction:
Respiratory viral pneumonias are a leading cause of severe respiratory failure and intensive care unit (ICU) admission worldwide. Although viral infection itself drives significant morbidity and mortality, secondary bacterial and fungal superinfections represent a critical 'double threat' in critically ill adults, exacerbating lung injury, prolonging organ dysfunction, and complicating antimicrobial management. Experience from the Influenza A (H1N1) pdm09 and SARS-CoV-2 pandemics highlights a persistent mismatch between low documented bacterial co-infection rates and widespread empiric antibiotic exposure, underscoring diagnostic uncertainty and antimicrobial stewardship challenges in the ICU.
Areas Covered:
This review examines the epidemiology, immunopathogenesis, and diagnostic approaches to bacterial and fungal superinfection in adult ICU patients with severe viral pneumonia. Evidence is synthesized from large ICU cohorts, pandemic data, and established consensus definitions for influenza- and COVID-19-associated pulmonary aspergillosis (IAPA, CAPA). The review discusses advances in molecular diagnostics, lower respiratory tract sampling, bronchoalveolar lavage - based mycology, and biomarker-guided strategies, with a focused literature search of ICU-specific studies.
Expert Opinion:
Bacterial and fungal superinfections, while infrequent, carry substantial clinical impact in severe viral pneumonia. A multimodal, ICU-adapted diagnostic strategy integrating pathogen detection with host-response assessment is essential to support timely therapy, enable antimicrobial de-escalation, and align superinfection management with stewardship principles.
Insights
Secondary bacterial and fungal superinfections complicate severe viral pneumonia in intensive care units (ICUs). A multimodal diagnostic strategy is essential for timely treatment and antimicrobial stewardship in critically ill adults.
Area of Science:
- Critical care medicine
- Infectious diseases
- Pulmonology
Background:
- Severe viral pneumonias, including influenza and COVID-19, frequently lead to intensive care unit (ICU) admission and respiratory failure worldwide.
- Secondary bacterial and fungal superinfections pose a significant threat in critically ill patients, worsening lung injury and complicating treatment.
- Current practices show a gap between low documented co-infection rates and high antibiotic use, highlighting diagnostic and antimicrobial stewardship challenges in ICUs.
Purpose of the Study:
- To review the epidemiology, immunopathogenesis, and diagnostic strategies for bacterial and fungal superinfections in adult ICU patients with severe viral pneumonia.
- To synthesize evidence from ICU cohorts, pandemic data, and consensus definitions for influenza- and COVID-19-associated pulmonary aspergillosis (IAPA, CAPA).
- To discuss advancements in molecular diagnostics, respiratory tract sampling, bronchoalveolar lavage-based mycology, and biomarker-guided approaches.
Main Methods:
- Literature search focused on ICU-specific studies related to viral pneumonia and superinfections.
- Synthesis of evidence from large ICU cohorts and pandemic data.
- Review of established consensus definitions for IAPA and CAPA.
Main Results:
- Bacterial and fungal superinfections, though infrequent, have a substantial clinical impact on severe viral pneumonia outcomes.
- Diagnostic uncertainty and challenges in antimicrobial management persist in ICUs.
- Advances in molecular diagnostics and biomarker strategies offer potential improvements.
Conclusions:
- A multimodal, ICU-adapted diagnostic strategy is crucial for managing superinfections in severe viral pneumonia.
- Integrating pathogen detection with host-response assessment aids timely therapy and antimicrobial de-escalation.
- Effective superinfection management aligns with antimicrobial stewardship principles in critical care settings.
Related Concept Videos
02:09Stereotype Threat and Self-fulfilling Prophecies
01:50Threats to Biodiversity
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
00:57Viral Recombination
01:29Fungal Group Zygomycota